Cx 5461 Mechanism

Here the authors show that cx 5461 a small molecule in clinical trials as rna polymerase inhibitor has g4 stablization properties and can be repurposed to target dna repair defective cancers cells. Cx 5461 is a first in class small molecule g quadruplex g4 stabiliser being developed for the treatment of haematological malignancies and solid tumours.

Senhwa Biosciences Inc Tw Ppt Download

Control Of Ribosomal Rna Transcription By Nutrients Intechopen

Cx 5461 Dna Rna Synthesis Inhibitor Read Reviews Product Use

Cx 5461 is safe at doses associated with clinical benefit and dermatologic aes are manageable.

Cx 5461 Mechanism Of Action

Recently the rrna synthesis inhibitors cx 5461 and bmh 21 have shown therapeutic potential in different cancer models 10 13 17. Here the authors show that cx 5461 a small molecule in clinical trials as rna polymerase inhibitor has g4 stablization properties and can be repurposed to target dna repair defective cancers cells.

Inhibition Of Pol I Transcription Treats Murine And Human Aml By

Industry Update

Patient Derived Models Of Abiraterone And Enzalutamide Resistant

In alamar blue cell viability assays cx 5461 had an average ic50 against 20 varied cell lines from those of pancreas prostate colorectal lung breast ovary etc of 78nm.